An Endometrial Cancer Study for Women With Recurrent or Persistent Endometrial Cancer
Public ClinicalTrials.gov record NCT03077698. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Endometrial Carcinoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, multi-center, single-arm, two-period Phase 2 study. The study will investigate the efficacy of Sodium Cridanimod in conjunction with progestin therapy in a population of subjects with recurrent or persistent endometrial cancer, who have failed progestin monotherapy or who have been identified as Progesterone Receptor (PrR) negative. All patients must have endometrial cancer PrR status determined from an archival sample at Screening. The PrR status (positive or negative) will be determined by central laboratory by ImmunoHistoChemistry (IHC) testing. There are two treatment periods and a follow-up period within the study.
Study identification
- NCT ID
- NCT03077698
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 25 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 14, 2017 (Actual)
- Primary completion
- Jul 17, 2020 (Actual)
- Completion
- Jul 17, 2020 (Actual)
- Last update posted
- Jun 7, 2022
2017 – 2020
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Providence St. Joseph Medical Center - Gynecology | Burbank | California | 91505 | — |
| University of California - Irvine Healthcare | Irvine | California | 92697 | — |
| UCLA | Los Angeles | California | 90024 | — |
| St. Josephs Heritage Healthcare | Santa Rosa | California | 95403 | — |
| University of Colorado School of Medicine, Division of Gynecologic Oncology | Aurora | Colorado | 80045 | — |
| Baptist MD Anderson Cancer Center | Jacksonville | Florida | 32207 | — |
| Florida Hospital Cancer Institute | Orlando | Florida | 32804 | — |
| Sarasota Memorial Health Care System | Sarasota | Florida | 34239 | — |
| Northside Hospital [University Gynecologic Oncology] | Atlanta | Georgia | 30342 | — |
| MUMC - Curtis and Elizabeth Anderson Cancer Institute | Savannah | Georgia | 31404 | — |
| Saint Alphonsus Regional Medical Center | Boise | Idaho | 83706 | — |
| RUSH University Medical Center | Chicago | Illinois | 60612 | — |
| University of Kentucky, Markey Cancer Center | Lexington | Kentucky | 40508 | — |
| Women's Cancer Care [Mary Bird Cancer Center at Tammany Parish Hospital] | Covington | Louisiana | 70433 | — |
| St. Dominic-Jackson Memorial Hospital | Jackson | Mississippi | 39216 | — |
| SUNY Downstate Medical Center | Brooklyn | New York | 11203 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27517 | — |
| University of Cincinnati Cancer Institute-UC Health Barrett Center | Cincinnati | Ohio | 45219 | — |
| Oklahoma Cancer Specialists and Research Institute, LLC | Tulsa | Oklahoma | 74146 | — |
| Magee Women's Hospital (UPMC) | Pittsburgh | Pennsylvania | 15213 | — |
| Rapid City Regional Cancer Care | Rapid City | South Dakota | 57701 | — |
| UT Southwestern | Dallas | Texas | 75390 | — |
| UT Galveston; University of Texas Medical Branch (UTMB) | Galveston | Texas | 77555 | — |
| Seattle Cancer Care Alliance / University of Washington | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03077698, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03077698 live on ClinicalTrials.gov.